• Tue, May 10, 2022

Yigal Nochomovitz Downgraded (ATRA) to Hold and Decreased Target to $200 on, May 10th, 2022

Yigal Nochomovitz of Citigroup, Downgraded "Atara Biotherapeutics, Inc." (ATRA) to Hold and Decreased Target from $575 to $200 on, May 10th, 2022.

Yigal has made no other calls on ATRA in the last 4 months.



There is 1 other peer that has a rating on ATRA. Out of the 1 peers that are also analyzing ATRA, 0 agree with Yigal's Rating of Hold.



This is the rating of the analyst that currently disagrees with Yigal


  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $550 on, Monday, March 28th, 2022

Like: 👍